India to Saudi Arabia: Apixaban Export Trade Route
India has recorded 18 verified shipments of Apixaban exported to Saudi Arabia, representing a combined trade value of $2.5M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $137.9K USD. The leading Indian exporter is MSN LABORATORIES PRIVATE LIMITED, which accounts for 75% of total export value with 9 shipments worth $1.9M USD. On the buying side, TO THE ORDER OF., is the largest importer in Saudi Arabia with $1.0M USD in purchases. The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED , NATCO PHARMA LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Saudi Arabia Apixaban corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $2.5M USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's apixaban manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $137.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with apixaban's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 36.4%, placing it at rank #12 among India's top apixaban export destinations globally.
On the import side, key buyers of Indian apixaban in Saudi Arabia include TO THE ORDER OF.,, SUDAIR PHARMA COMPANY, TO THE ORDER OF., and 4 others. TO THE ORDER OF., is the single largest importer with 3 shipments valued at $1.0M USD.
